Literature DB >> 9143616

Vaccine therapy in early HIV-1 infection using a recombinant canarypox virus expressing gp160MN (ALVAC-HIV): a double-blind controlled randomized study of safety and immunogenicity.

R Tubiana, E Gomard, H Fleury, M L Gougeon, B Mouthon, H Picolet, C Katlama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9143616

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  2 in total

Review 1.  Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.

Authors:  Monica Vaccari; Poonam Poonam; Genoveffa Franchini
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

Review 2.  Therapeutic HIV vaccines: an update.

Authors:  Yves Lévy
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.495
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.